Ryan Specialty Group Holdings Inc
NYSE:RYAN
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
50.29
75.93
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
RYAN
stock under the Base Case scenario is
51.36
USD.
Compared to the current market price of 50.48 USD,
Ryan Specialty Group Holdings Inc
is
Undervalued by 2%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Ryan Specialty Group Holdings Inc.
| US |
|
Marsh & McLennan Companies Inc
NYSE:MMC
|
|
| IE |
|
Aon PLC
NYSE:AON
|
|
| US |
|
Arthur J Gallagher & Co
NYSE:AJG
|
|
| US |
A
|
Arthur J. Gallagher & Co.
SWB:GAH
|
|
| UK |
W
|
Willis Towers Watson PLC
NASDAQ:WTW
|
|
| US |
|
Brown & Brown Inc
NYSE:BRO
|
|
| IN |
|
PB Fintech Ltd
NSE:POLICYBZR
|
|
| US |
|
Hagerty Inc
NYSE:HGTY
|
|
| AU |
|
Steadfast Group Ltd
ASX:SDF
|
|
| US |
|
BRP Group Inc
NASDAQ:BWIN
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Ryan Specialty’s heavy reliance on the excess and surplus (E&S) market makes it vulnerable to industry cycles, and in a softening market, the firm’s premium growth could slow rapidly, pressuring revenue and margins.
Its aggressive expansion strategy through multiple acquisitions could trigger integration challenges and heightened operational complexity, potentially disrupting synergy captures and incurring higher-than-expected costs.
Increased competition from both established wholesale brokers and tech-savvy insurtech entrants poses a risk to Ryan Specialty’s specialty niches, threatening its ability to maintain premium pricing power and specialized market share.
Ryan Specialty’s strong foothold in niche E&S segments positions it favorably to maintain robust pricing and capture higher-margin business, steadily outpacing broader insurance distribution growth rates.
The company’s history of successfully integrating acquired businesses has bolstered its diversified specialty product lineup, and continued M&A-driven acquisitions could further strengthen its leadership in underserved insurance niches.
Its scale and long-standing relationships with top carriers and retail brokers provide a resilient distribution network, allowing Ryan Specialty to command premium rates and sustain stable margins even in volatile insurance cycles.
Revenue & Expenses Breakdown
Ryan Specialty Group Holdings Inc
Balance Sheet Decomposition
Ryan Specialty Group Holdings Inc
| Current Assets | 4.4B |
| Cash & Short-Term Investments | 153.5m |
| Receivables | 4.2B |
| Other Current Assets | 65.6m |
| Non-Current Assets | 5.4B |
| Long-Term Investments | 101.8m |
| PP&E | 204.3m |
| Intangibles | 4.7B |
| Other Non-Current Assets | 349.1m |
| Current Liabilities | 4.5B |
| Accounts Payable | 243.3m |
| Accrued Liabilities | 385.2m |
| Other Current Liabilities | 3.8B |
| Non-Current Liabilities | 4.8B |
| Long-Term Debt | 3.3B |
| Other Non-Current Liabilities | 1.4B |
Free Cash Flow Analysis
Ryan Specialty Group Holdings Inc
| USD | |
| Free Cash Flow | USD |
Earnings Waterfall
Ryan Specialty Group Holdings Inc
|
Revenue
|
3B
USD
|
|
Operating Expenses
|
-2.3B
USD
|
|
Operating Income
|
656.1m
USD
|
|
Other Expenses
|
-585.6m
USD
|
|
Net Income
|
70.5m
USD
|
RYAN Profitability Score
Profitability Due Diligence
Ryan Specialty Group Holdings Inc's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
Score
Ryan Specialty Group Holdings Inc's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
RYAN Solvency Score
Solvency Due Diligence
Ryan Specialty Group Holdings Inc's solvency score is 24/100. The higher the solvency score, the more solvent the company is.
Score
Ryan Specialty Group Holdings Inc's solvency score is 24/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
RYAN Price Targets Summary
Ryan Specialty Group Holdings Inc
According to Wall Street analysts, the average 1-year price target for
RYAN
is 66.6 USD
with a low forecast of 58.58 USD and a high forecast of 79.8 USD.
Dividends
Current shareholder yield for
RYAN is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
RYAN
stock under the Base Case scenario is
51.36
USD.
Compared to the current market price of 50.48 USD,
Ryan Specialty Group Holdings Inc
is
Undervalued by 2%.